Alon Lazarus

Alon Lazarus formerly worked at Paros Bio, Inc., as Director, Reunion Neuroscience, Inc., as Director, Lutris Pharma Ltd., as Director, Werewolf Therapeutics, Inc., as Independent Director from 2019 to 2024, Entact Bio, Inc., as Director, Photys Therapeutics, Inc., as Director, Auron Therapeutics, Inc., as Director, Pantheon Biosciences Ltd., as Director, Keros Therapeutics, Inc., as Independent Director from 2016 to 2020, Quiet Therapeutics Ltd., as Director, Oncorus, Inc., as Director from 2016 to 2019, Entact Bio Ltd., as Director from 2019 to 2023, Arkin Bio Ventures, as Biotech Investment Manager from 2013 to 2024, Yissum Holdings Ltd., as Head-Business Development from 2012 to 2013, Arkin Holdings, as Manager-Biotech Investment, and Integra Holdings Ltd., as Analyst.
Dr. Lazarus received his doctorate degree from The Hebrew University Hadassah Medical School and undergraduate degree and Masters Business Admin degree from The Hebrew University of Jerusalem.